central nervous system

(redirected from Central nervous system diseases)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for central nervous system

References in periodicals archive ?
Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics(TM), a new class of drugs for the treatment of central nervous system diseases and disorders.
Human coronaviruses (HCoVs) were first recorded in the late 1960s; they are associated mainly with respiratory tract illness but are also involved in enteric and central nervous system diseases.
Mitsubishi Pharma Corporation is a global research-driven pharmaceutical company targeting the therapeutic areas of cardiovascular and metabolic diseases, psychiatric and central nervous system diseases, immunological and respiratory diseases, and cancer and hepatic disease.
The nonprofit group sends medical professionals to developing nations to train local physicians to treat children born with central nervous system diseases.
DOV Pharmaceuticals has selected etrials, a provider of technologies and services for the healthcare and pharmaceutical industries, to provide electronic data capture (EDC) services in clinical studies related to central nervous system diseases (CNS).
Overall, this is a good, practical guide to differential diagnosis of central nervous system diseases encountered in the neurosurgery-surgical pathology area, and it is particularly handy for practicing pathologists in community hospitals.
In another analysis, central nervous system specimens were positive for active HHV-6 infection in 8 of 11 MS patients, none of 7 healthy controls, and 2 of 21 patients with other central nervous system diseases.
To date, Millennium has delivered three novel genes implicated in central nervous system diseases to Wyeth-Ayerst, all resulting in milestone payments to Millennium.
Through its activity on the mast cell and certain kinases essential to the activation of the inflammatory cells and fibrosing tissue remodeling, masitinib can have an effect on the symptoms associated with some inflammatory and central nervous system diseases.
According to Supernus Pharmaceuticals, it is a specialty pharmaceutical company that is focused on developing and commercialising products for the treatment of central nervous system diseases.
Accompanying an increased number of products, the range of therapeutic areas that MRs handle has also been broadly widened to cover medical information distribution activities for lifestyle-related diseases, Central Nervous System diseases, Oncology, and more.
Solvay Pharmaceuticals Conference on Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases (8th: 2007: Nice, France).
The products are used within oncology and the treatment of asthma/chronic obstructive pulmonary diseases, infectious diseases and central nervous system diseases.
It s core therapeutic areas are psychiatric and central nervous system diseases, cardiovascular and metabolic diseases, immunological and respiratory diseases, and cancer and hepatic diseases.
Full browser ?